z-logo
open-access-imgOpen Access
Pyridoxal-5′-phosphate-dependent alkyl transfer in nucleoside antibiotic biosynthesis
Author(s) -
Zheng Cui,
Jonathan Overbay,
Xiachang Wang,
Xiaodong Liu,
Yinan Zhang,
Minakshi Bhardwaj,
Anke Lemke,
Daniel D. Wiegmann,
Giuliairo,
Jon S. Thorson,
Christian Ducho,
Steven G. Van Lanen
Publication year - 2020
Publication title -
nature chemical biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.412
H-Index - 216
eISSN - 1552-4469
pISSN - 1552-4450
DOI - 10.1038/s41589-020-0548-3
Subject(s) - chemistry , nucleoside , stereochemistry , disaccharide , biosynthesis , nucleotide , pyridoxal , alkyl , glycosidic bond , biochemistry , phosphate , enzyme , organic chemistry , gene
Several nucleoside antibiotics are structurally characterized by a 5″-amino-5″-deoxyribose (ADR) appended via a glycosidic bond to a high-carbon sugar nucleoside (5'S,6'S)-5'-C-glycyluridine (GlyU). GlyU is further modified with an N-alkylamine linker, the biosynthetic origin of which has yet to be established. By using a combination of feeding experiments with isotopically labeled precursors and characterization of recombinant proteins from multiple pathways, the biosynthetic mechanism for N-alkylamine installation for ADR-GlyU-containing nucleoside antibiotics has been uncovered. The data reveal S-adenosyl-L-methionine (AdoMet) as the direct precursor of the N-alkylamine, but, unlike conventional AdoMet- or decarboxylated AdoMet-dependent alkyltransferases, the reaction is catalyzed by a pyridoxal-5'-phosphate-dependent aminobutyryltransferase (ABTase) using a stepwise γ-replacement mechanism that couples γ-elimination of AdoMet with aza-γ-addition onto the disaccharide alkyl acceptor. In addition to using a conceptually different strategy for AdoMet-dependent alkylation, the newly discovered ABTases require a phosphorylated disaccharide alkyl acceptor, revealing a cryptic intermediate in the biosynthetic pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here